Flotillin-1(FLOT1), a marker of lipid raft, is recently reported to be overexpressed and correlate with advanced tumor stage as well as poor patient survival in various types of human cancer, including breast, esophageal, liver and lung cancer [16–19]. Here, FLOT1 is linked to lung cancer.